Emerging markets output growth rises slightly in April - HSBC survey
LONDON (Reuters) - Business activity across emerging markets expanded slightly in April following four months of declining growth, but output fell in all the BRIC emerging economies, a survey showed on Thursday.
HSBC's composite emerging markets index of manufacturing and services purchasing managers' surveys edged up to 50.4 from 50.3 in March, but remained well below its long-run trend level of 53.9.
The data showed declining output in the four largest economies, Brazil, Russia, India and China - below the 50 threshold that marks the difference between expansion and contraction.
Based on data from purchasing managers at about 8,000 firms in 17 countries, the survey showed manufacturing output across emerging markets was broadly stagnant in April, while services activity growth was unchanged from March's weak rate.
"Big economies from Russia, Turkey, Poland to South Africa all lost momentum," said Murat Ulgen, HSBC chief economist for central and eastern Europe and sub-Saharan Africa, in a statement.
The future output index, which tracks firms' expectations for activity in 12 months' time, fell to a new low in April, mainly reflecting a sharp weakening in output expectations in Brazil and Mexico and the weakest sentiment in China in 2014 so far.
The HSBC index is calculated using data produced by Markit.
(Reporting by Carolyn Cohn; Editing by Toby Chopra)
- Tweet this
- Share this
- Digg this
- In India, rice replaces ice in bucket challenge
- Ukraine seeks to join NATO; defiant Putin compares Kiev to Nazis
- U.S. strikes have slowed Iraq militants but not weakened them - Pentagon
- Comedian Joan Rivers remains in serious condition at N.Y. hospital
- UPDATE 1-Don't mess with nuclear Russia, Putin says
India's economy grew by a faster-than-expected 5.7 percent in the three months through June, its fastest pace in two-and-a- half years, helped by a rebound in manufacturing and mining sectors, government data showed on Friday. Full Article
Exclusive: Reliance plans $13 billion projects including new refinery. Full Article
In race for bigger margins, drug makers willing to lose the India "advantage". Full Article